L’Oréal’s Anthelios SX Will Launch Following FDA Approval Of UVA Filter
This article was originally published in The Rose Sheet
Executive SummaryL'Oréal will introduce Anthelios SX, the first product on the U.S. market containing a sun filter for short UVA wave protection this fall, the company announced July 24
You may also be interested in...
The Sunscreen Innovation Act may have served to clear FDA’s queue of pending sunscreen TEAs, but with denials across the board due to insufficient data, the Public Access to Sunscreens coalition questions the tenability of FDA’s standards and approach to review. The denial of L’Oreal’s TEA for ecamsule, an ingredient already available OTC through a new drug approval, only reinforces PASS’ view that FDA is resistant to working outside of the NDA pathway.